Thomas, N., Juckel, J., Daly, C., & Salom, C. (2021). Queensland Drug Trends 2020: Key Findings From The Illicit Drug Reporting Systeym (IDRS) Interviews [10.26190/wgmn-m489](978-0-7334-3969-8). https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/IDRS_QLD_Report_FINAL_0.pdf

Thygesen, H., Bonsaksen, T., Schoultz, M., Ruffolo, M., Leung, J., Price, D., & Geirdal, A. Ø. (2021). Use and self-perceived effects of social media before and after the COVID-19 outbreak: a cross-national study [10.1007/s12553-021-00595-x]. Health and Technology, 11(6), 1347-1357. https://doi.org/10.1007/s12553-021-00595-x

Tinner, L., Wright, C., Heron, J., Caldwell, D., Campbell, R., & Hickman, M. (2021). Correction to: Is adolescent multiple risk behaviour associated with reduced socioeconomic status in young adulthood and do those with low socioeconomic backgrounds experience greater negative impact? Findings from two UK birth cohort studies (BMC Public Health, (2021), 21, 1, (1614), 10.1186/s12889-021-11638-3) [10.1186/s12889-021-11764-y]. BMC Public Health, 21(1). https://doi.org/10.1186/s12889-021-11764-y

Tisdale, C., de Andrade, D., Leung, J., Chiu, V., & Hides, L. (2021). Utilising data linkage to describe and explore mortality among a retrospective cohort of individuals admitted to residential substance use treatment [10.1111/dar.13279]. Drug and Alcohol Review, 40(7), 1202-1206. https://doi.org/10.1111/dar.13279

Tran, D., Falster, M., Pearson, S., & Jorm, L. (2021). Health Care Homes Practice Benchmark Report: July 2020 - December 2020 (Round 5).

Treloar, C., Schroeder, S., Lafferty, L., Marshall, A., Drysdale, K., Higgs, P., Baldry, E., Stoove, M., & Dietze, P. (2021). Structural competency in the post-prison period for people who inject drugs: A qualitative case study [10.1016/j.drugpo.2021.103261]. International Journal of Drug Policy, 95. https://doi.org/10.1016/j.drugpo.2021.103261

Turner, A., Baker, A., Dean, O. M., Walker, A. J., Dodd, S., Cotton, S. M., Scott, J. G., Kavanagh, B. E., Ashton, M. M., Brown, E., McGrath, J. J., & Berk, M. (2021). Adjunctive Garcinia mangostana Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d’appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d’efficacité de 24 semaines, à double insu, randomisé et contrôlé par placebo [10.1177/0706743720982437]. Canadian Journal of Psychiatry, 66(4), 354-366. https://doi.org/10.1177/0706743720982437

Uporova, J., Peacock, A., & Sutherland, R. (2021). Naloxone cascade of care among a sample of people who inject drugs in Canberra, ACT [10.26190/vmde-sz12].

Uporova, J., Price, O., Karlsson, A., & Peacock, A. (2021). Australian Capital Territory Drug Trends 2020: Key Findings from the Illicit Drug Reporting System (IDRS) Interviews [10.26190/jpxh-t685]. https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/ACT_IDRS_2020_final.pdf

Valerio, H., Alavi, M., Law, M., McManus, H., Tillakeratne, S., Bajis, S., Martinello, M., Matthews, G. V., Amin, J., Janjua, N. Z., Krajden, M., George, J., Degenhardt, L., Grebely, J., & Dore, G. J. (2021). Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage Study [10.1093/cid/ciab526]. Clinical Infectious Diseases, 73(11), 2037-2044. https://doi.org/10.1093/cid/ciab526

Valerio, H., Alavi, M., Silk, D., Treloar, C., Martinello, M., Milat, A., Dunlop, A., Holden, J., Henderson, C., Amin, J., Read, P., Marks, P., Degenhardt, L., Hayllar, J., Reid, D., Gorton, C., Lam, T., Dore, G., & Grebely, J. (2021). Progress towards Elimination of Hepatitis C Infection among People Who Inject Drugs in Australia: The ETHOS Engage Study [10.1093/cid/ciaa571]. Clinical Infectious Diseases, 73(1), E69-E78. https://doi.org/10.1093/cid/ciaa571